[Cleavage of concatamer-type substrates by restriction endonucleases MVA1 and SSO1I].
The interaction of enzymes SsoII (decreases CCNGG) and MvaI (CC decreases A/TGG) with concatemeric DNA duplexes used earlier to study EcoRII (decreases CCA/TGG) TGG was investigated with a view of elucidating the general principles of the restriction endonuclease function. A pattern common for all the three enzymes was observed with DNA duplexes containing AA or TT pairs in the central position of the recognition site. The AA pair blocks or substantially hinders the endonuclease action, whereas the TT pair is either less inhibitory or altogether inert. SsoII, similar to EcoRII was able to processively cleave the concatemeric substrates and to interact with (or to be close to) the hydrogen in the 5th position of the outer dC residue of the recognition site. MvaI was found to differ from EcoRII in the way they recognize and cleave the same nucleotide sequence. The substrate-bound MvaI molecule is incapable of linear diffusion along the DNA. Effective hydrolysis of dU- and m5dC-containing polymers rules out the participation of hydrophobic contacts of the enzyme with the methyl group of the dT residue and with the 5th hydrogen of the outer dC residue of the recognition site in DNA-protein interactions.
Gromova
E S
ES
Kubareva
E A
EA
Elov
A A
AA
Akatova
E A
EA
Nikol'skaia
I I
II
Shabarova
Z A
ZA
D001345:Autoradiography; D001483:Base Sequence; D004268:DNA-Binding Proteins / Q000378:metabolism; D015257:DNA-Cytosine Methylases / Q000378:metabolism*; D015252:Deoxyribonucleases, Type II Site-Specific / Q000378:metabolism*; D004591:Electrophoresis, Polyacrylamide Gel; D006868:Hydrolysis; D008969:Molecular Sequence Data; D009693:Nucleic Acid Hybridization; D013379:Substrate Specificity
D004268:DNA-Binding Proteins; C029528:DNA modification methylase EcoRII; D015257:DNA-Cytosine Methylases; C045297:CCNGG-specific type II deoxyribonucleases; D015252:Deoxyribonucleases, Type II Site-Specific
Rasshcheplenie substratov konkatemernogo tipa éndonukleazami restriktsii MVAI i SSO1I.